A review of experimental, clinical, and imaging evidence proposes that coronary microvascular dysfunction may promote ...
Neurointerventional robots have long remained at the stage of 'only being able to assist with angiography.' Through close medical-engineering collaboration with Professor Jianmin Liu's team at ...
This is my personal experience from seven years ago when I had surgery for retinopathy. 👁️ Basic Examinations at the ...
The U.S. Food and Drug Administration (FDA) has cleared Elucid's FFR-IQ software for the noninvasive estimation of fractional flow reserve from coronary CT angiography (FFR-CT). The artificial ...
AngioInsight Inc. has enrolled the first patient in the SMARTFLOW clinical study that will evaluate AngioAI+, its investigational software platform designed to assess coronary physiology from routine ...
IQ, introducing BioIntegrated FFR-CT with 92.2% sensitivity and 93.1% specificity to evaluate coronary ischemia.
The ELUCIDATE FFR-CT study, which supported Elucid's recent US FDA 510 (k) clearance of FFR-IQ, demonstrated an overall sensitivity of 92.2% and specificity of 93.1%, the highest of any FFR-CT ...
A 10-year retrospective study found high observed specificity but incomplete sensitivity for transcranial Doppler in ...
Srinivas Attanti, MD, FACC Cardiologist and Interventional Cardiologist Citrus Cardiology Consultants, PLLC Florida ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results